Literature DB >> 28810254

Insulin Influences LPS-Induced TNF-α and IL-6 Release Through Distinct Pathways in Mouse Macrophages from Different Compartments.

Fernando H G Tessaro, Thais S Ayala, Eduardo L Nolasco, Leonardo M Bella, Joilson O Martins.   

Abstract

BACKGROUND/AIMS: Diabetic subjects are more susceptible to infections, which is partially due to insulin deficiency and hyperglycemia. We hypothesized that insulin influences cytokine release by macrophages from diabetic C57BL/6 mice stimulated with lipopolysaccharides (LPS).
METHODS: Bone marrow-derived macrophages (BMDM) and tissue-specific macrophages from diabetic (alloxan 60 mg/kg, i.v.) male C57BL/6 mice were stimulated by LPS (100 ng/mL) and/or treated by insulin (1 mU/mL).
RESULTS: Using BMDM from diabetic mice, we showed that LPS induced an increase in TNF-α and IL-6 release and p38, SAPK/JNK, ERK 1/2, and Akt (308-Thr and 473-Ser) phosphorylation but not in PKCα/β II and delta. Insulin increased TNF-α and IL-6 secretion in LPS-stimulated macrophages as well as p-p38, p-SAPK/JNK, p-ERK 1/2, p-PI3K (p55) and p-Akt (473-Ser) expression. Furthermore, PI3-kinase inhibition by wortmannin decreased TNF-α release, and inhibition by LY294002 decreased both TNF-α and IL-6 levels after LPS-insulin treatment. PD98059, which inhibits the ERK upstream activators MAPK kinase (MKK) 1 and MKK2, reduced the effect promoted by insulin in BMDM stimulated by LPS In tissue-specific macrophages, insulin reduced LPS-induced TNF-α, IL-6 and IL-1β secretion in alveolar and peritoneal macrophages.
CONCLUSION: These data suggest that insulin through the modulation of PI3-kinase and ERK 1/2 pathways drive different responses in macrophages, thereby enhancing our understanding of the plasticity of these cells.
© 2017 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Akt; Alloxan; Diabetes; ERK; Macrophage; PI3K

Mesh:

Substances:

Year:  2017        PMID: 28810254     DOI: 10.1159/000479904

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  14 in total

Review 1.  Liver macrophages and inflammation in physiology and physiopathology of non-alcoholic fatty liver disease.

Authors:  Ronan Thibaut; Matthew C Gage; Inès Pineda-Torra; Gwladys Chabrier; Nicolas Venteclef; Fawaz Alzaid
Journal:  FEBS J       Date:  2021-05-02       Impact factor: 5.622

2.  Effect of lipopolysaccharide derived from surabaya isolates of Actinobacillus actinomycetemcomitans on alveolar bone destruction.

Authors:  Rini Devijanti Ridwan; Tuti Kusumaningsih; Sherman Salim
Journal:  Vet World       Date:  2018-02-10

3.  Ibrutinib suppresses LPS-induced neuroinflammatory responses in BV2 microglial cells and wild-type mice.

Authors:  Hye Yeon Nam; Jin Han Nam; Gwangho Yoon; Ju-Young Lee; Youngpyo Nam; Hye-Jin Kang; Hyun-Ji Cho; Jeongyeon Kim; Hyang-Sook Hoe
Journal:  J Neuroinflammation       Date:  2018-09-19       Impact factor: 8.322

4.  Breast Milk-Derived Extracellular Vesicles Enriched in Exosomes From Mothers With Type 1 Diabetes Contain Aberrant Levels of microRNAs.

Authors:  Aashiq H Mirza; Simranjeet Kaur; Lotte B Nielsen; Joachim Størling; Reza Yarani; Martin Roursgaard; Elisabeth R Mathiesen; Peter Damm; Jens Svare; Henrik B Mortensen; Flemming Pociot
Journal:  Front Immunol       Date:  2019-10-25       Impact factor: 7.561

5.  Dehydroandrographolide inhibits mastitis by activating autophagy without affecting intestinal flora.

Authors:  Wenjin Guo; Juxiong Liu; Yufei Zhang; He Ma; Yuhang Li; Qian Gong; Yu Cao; Guiqiu Hu; Shengnan Xie; Shoupeng Fu
Journal:  Aging (Albany NY)       Date:  2020-07-23       Impact factor: 5.682

6.  Immune System Effects of Insulin-Like Peptide 5 in a Mouse Model.

Authors:  Brett Vahkal; Sergey Yegorov; Chukwunonso Onyilagha; Jacqueline Donner; Dean Reddick; Anuraag Shrivastav; Jude Uzonna; Sara V Good
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-14       Impact factor: 5.555

7.  Endangered Lymphocytes: The Effects of Alloxan and Streptozotocin on Immune Cells in Type 1 Induced Diabetes.

Authors:  Luiz A D Queiroz; Josiane B Assis; João P T Guimarães; Emanuella S A Sousa; Anália C Milhomem; Karen K S Sunahara; Anderson Sá-Nunes; Joilson O Martins
Journal:  Mediators Inflamm       Date:  2021-10-19       Impact factor: 4.711

Review 8.  Targeting NLRP3 Inflammasome in the Treatment Of Diabetes and Diabetic Complications: Role of Natural Compounds from Herbal Medicine.

Authors:  Ying Bai; Qianqian Mu; Xueli Bao; Jiacheng Zuo; Xin Fang; Jing Hua; Dongwei Zhang; Guangjian Jiang; Ping Li; Sihua Gao; Dandan Zhao
Journal:  Aging Dis       Date:  2021-10-01       Impact factor: 9.968

Review 9.  Impact of diabetes mellitus simulations on bone cell behavior through in vitro models.

Authors:  Yihan Li; Annie Shrestha; Hongmei Zhang; Lingjie Li; Dize Li; Tiwei Fu; Jinlin Song; Ping Ji; Yuanding Huang; Tao Chen
Journal:  J Bone Miner Metab       Date:  2020-05-16       Impact factor: 2.626

Review 10.  Diabetes and susceptibility to infections: Implication for COVID-19.

Authors:  Gustav van Niekerk; Michelle van der Merwe; Anna-Mart Engelbrecht
Journal:  Immunology       Date:  2021-06-24       Impact factor: 7.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.